The Ohio State University Medical Center are studying a potentially long-term treatment that involves injecting a gene directly into one of the critical feeding and weight control centers of the brain. "Obesity significantly increases the risk for diabetes, cardiovascular disease, stroke and some cancers," says Dr. Matthew During, senior author and professor in Ohio State Medical Center's department of molecular virology, immunology and medical genetics.
"Our findings represent a promising new treatment for obesity that could ultimately provide a much safer and more effective approach than some conventional therapies." Scientists have discovered that a particular gene, BDNF, can result in improved insulin sensitivity, reduced fat mass and weight loss when active in the hypothalamus. The findings are published online in the journal Nature Medicine.
Read more on: Medical News Today